Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2011
2024
Serving as an Employee Representative on the Board of Directors at Investinor
2021
As an Investment Director at Investinor, Norway's largest venture capital firm, I hold multiple key responsibilities: Lead role in portfolio management: I manage our ownership interests in a diverse range of portfolio companies across various industries, including construction management software, digital healthcare, aquaculture technology, and nutraceuticals. This involves strategic oversight, guiding growth initiatives, and ensuring value creation for our investments. Fund manager: I serve as the fund manager for two of Investinor's venture funds. In this role, I coordinate investment decisions and ensure that the funds achieve their financial goals, maintaining a balanced and high-performing portfolio. Board representation: In addition to my investment and managerial duties, I am the employee representative on the Board of Directors at Investinor, contributing to the governance and strategic direction of the firm. My role at Investinor allows me to leverage my expertise in venture capital to drive innovation and growth in cutting-edge industries while ensuring robust governance and strategic alignment within the firm.
2019 - 2021
In my role as Investment Manager at Investinor, I served as Head of Seed Investments, managing a portfolio of approximately 30 fast-growing tech companies. I also led larger venture investments and represented Investinor on the boards of directors at Planktonic AS and Dele Health Tech AS.
2017 - 2018
In my role as Senior Associate at Investinor, I served as Head of Seed Investments, managing a portfolio of approximately 20 fast-growing tech companies. I also participated in larger venture investments and represented Investinor on the boards of directors at Planktonic AS and Vitux Group AS.
2011 - 2017
During my tenure as an Associate at Investinor, I gained extensive experience in investing in private companies, contributing to various aspects of the investment process. My roles included analyzing investment opportunities, conducting due diligence, negotiating deals, and exercising active ownership from the boardroom. This experience not only equipped me with a deep understanding of venture capital and private equity but also enabled me to build a substantial network within the seed, venture, corporate investor, and family office communities.
2024
2024
As a Board Member at Fonn, I represent Investinor, the largest owner in the company. Fonn provides a cutting-edge construction management software solution tailored for house builders in the Norwegian and UK markets. In my role, I provide strategic oversight and guidance to help Fonn expand its market presence and enhance its software offerings.
2020
2023
In July 2023, I successfully led the negotiation team on behalf of DHT in its sale to Vayyar Imaging Ltd., a unicorn and global leading semiconductor company that produces 4D imaging radar sensors. This strategic transaction underscores the significant value of DHT's innovative technology and its crucial role in enhancing Vayyar's portfolio. The integration of DHT's fall-detection technology for seniors is set to play a pivotal role on the global stage, reinforcing Vayyar's position as a leader in this vital market segment. Following this transaction, I will be assuming the role of Chair of the Board for DHT. Moving forward, DHT will pivot into a holding company with the sole objective of managing its new ownership stake in Vayyar and Pratexo. I am proud to have contributed to this milestone, ensuring that our developed technology continues to make a substantial impact in the industry.
2020 - 2023
As a Board Member at Dele Health Tech, I represented the lead investor and played a key role in expanding the business from Norway to the US senior healthcare market. Dele Health Tech provides a fall detection, alert, and management system with four times the accuracy of other automated systems, ensuring real-time alerts for staff in senior living and nursing facilities. Addressing the critical issue of falls, which affect one in three seniors over 65 annually and account for 70% of deaths among those over 75, our technology leverages extensive IoT health application experience. We manage large data volumes to make fall detection predictive and preventive, significantly enhancing resident safety and quality of care.
2015
2015
As a Board Member at Planktonic, I represent Investinor, the lead investor and largest shareholder in the company, which pioneers innovative live starter feed solutions for marine aquaculture. Planktonic's cutting-edge approach streamlines logistics and enhances ease of use while maintaining the highest quality standards and competitive pricing in the industry. In this role, I provide strategic guidance and oversight, driving growth initiatives and operational improvements. Leveraging my expertise in venture capital and corporate governance, I help shape the company’s strategic direction, ensuring it remains at the forefront of the aquaculture sector while meeting investor expectations and expanding its market footprint.
2012
2012
As a Deputy Board Member at Cryogenetics, I represent Investinor and contribute to the company's growth and strategic direction. Cryogenetics is a global leader in fish reproduction technology, offering services like cryopreservation of fish milt and other related products. With laboratories in Norway, Chile, Canada, the USA, and the UK, Cryogenetics has successfully scaled its business globally and into profitably. My primary responsibilities include securing Investinor's initial and follow-on investments, contributing to business development and strategy, and playing a key role in recruiting the CEO. Through these efforts, I help drive Cryogenetics' continued success and industry leadership.
2017 - 2024
2020 - 2024
Involved in the successful sale of shares to a financial buyer. Contributed in the transformation of Vitux from an industrial startup with NOK 50m annual turnover to a global supplier in the nutraceutical and dietary supplement industry, reaching over NOK 360m in turnover and more than NOK 60m EBITDA in 2024. Contributed to the commercialization and growth of Vitux's patented ConCordix technology, enhancing the company's position as a third-party manufacturer for private label products.
2017 - 2020
Vitux is a third-party manufacturer providing private label products for the nutraceutical and dietary supplement industry. The business opportunity is based on the revolutionary and patented ConCordix technology. The organisation is established in Oslo with a manufacturing site in Andenes, Norway.
2016 - 2021
2016 - 2021
Keep-it Technologies has developed a proprietary, low cost, and easy-to-read freshness indicator that addresses the waste issue related to date labeling.
2012 - 2018
2012 - 2018
Played a role in the strategic sale of Havgul’s assets to a leading industrial buyer in the renewable energy sector. - Focused on maximizing shareholder value while representing Investinor’s interests on the board. - Contributed to the development of some of Norway’s largest onshore and offshore wind power projects, supporting the company’s commitment to environmental sustainability and renewable energy. - Collaborated with various stakeholders to ensure alignment with long-term business and environmental goals in the wind energy industry.
2006 - 2011
2010 - 2011
2006 - 2011
At NorgesInvestor Sec I structured, marketed and traded OTC derivatives. I priced exotic derivatives backed on equity, commodities and FX. We traded directly with investment banks like Goldman Sachs, UBS, Deutsche Bank, Lehman brothers and others. One of my task was also to monitor and analyze global macro trends, and thus find new investment opportunities for our investors. During my time in NIS I structured derivatives that traded at a total exposure of several 100 MNOK.
2003 - 2005
2003 - 2005